Best Penny Stocks Under 50 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.50 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.50. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Stem NYSE:STEM$0.35 0.00 (0.00%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems. More about StemMarket Capitalization$56.96 millionP/E Ratio-0.07Consensus RatingHoldConsensus Price Target$1.11 (+220.2% Upside)Volume1.68 million sharesAverage Volume9.86 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Sunnova Energy International NYSE:NOVA$0.28 -0.03 (-8.73%) As of 11:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Sunnova Energy International Inc engages in the provision of energy as a service in the United States. The company offers electricity, as well as offers operations and maintenance, monitoring, repairs and replacements, equipment upgrades, on-site power optimization, and solar energy system and energy storage system diagnostics services. More about Sunnova Energy InternationalMarket Capitalization$34.77 millionP/E Ratio-0.08Consensus RatingHoldConsensus Price Target$5.37 (+1,838.5% Upside)Volume5.38 million sharesAverage Volume11.00 million shares3. Lexicon Pharmaceuticals NASDAQ:LXRX$0.47 +0.06 (+13.15%) As of 11:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Lexicon Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. More about Lexicon PharmaceuticalsMarket Capitalization$116.96 millionP/E Ratio-0.63Consensus RatingHoldConsensus Price Target$3.67 (+673.6% Upside)Volume8.28 million sharesAverage Volume6.15 million shares4. WW International NASDAQ:WW$0.49 -0.03 (-6.61%) As of 11:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.WW International, Inc provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. More about WW InternationalMarket Capitalization$38.94 millionP/E Ratio-0.08Consensus RatingHoldConsensus Price Target$3.00 (+517.3% Upside)Volume774,745 sharesAverage Volume4.48 million shares5. Chegg NYSE:CHGG$0.48 -0.03 (-5.68%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Chegg, Inc operates a direct-to-student learning platform that helps learners build essential life and job skills to accelerate their path from learning programs in the United States and internationally. More about CheggMarket Capitalization$50.66 millionP/E Ratio-0.06Consensus RatingReduceConsensus Price Target$2.08 (+332.2% Upside)Volume1.68 million sharesAverage Volume3.27 million shares6. Nikola NASDAQ:NKLA$0.18 -0.07 (-28.74%) Closing price 02/25/2025Extended Trading$0.18 0.00 (0.00%) As of 02/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about NikolaMarket Capitalization$11.14 millionP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$12.00 (+6,457.4% Upside)Volume36.66 million sharesAverage Volume8.32 million sharesRemove Ads7. Applied Therapeutics NASDAQ:APLT$0.42 -0.01 (-2.74%) As of 11:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Applied Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. More about Applied TherapeuticsMarket Capitalization$49.22 millionP/E Ratio-0.26Consensus RatingModerate BuyConsensus Price Target$6.10 (+1,342.1% Upside)Volume1.32 million sharesAverage Volume3.08 million shares8. GlycoMimetics NASDAQ:GLYC$0.18 0.00 (-1.11%) As of 11:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.GlycoMimetics, Inc, a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. More about GlycoMimeticsMarket Capitalization$11.68 millionConsensus RatingHoldVolume245,541 sharesAverage Volume6.74 million sharesToday's Range$0.18▼$0.1850-Day Range$0.18▼$0.369. Genprex NASDAQ:GNPX$0.32 -0.02 (-5.67%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Genprex, Inc, a clinical-stage gene therapy company, focuses on developing gene-based therapies for patients with cancer and diabetes in the United States. More about GenprexMarket Capitalization$2.69 millionConsensus RatingBuyConsensus Price Target$10.00 (+3,064.6% Upside)Volume2.20 million sharesAverage Volume3.52 million sharesToday's Range$0.26▼$0.3310. CytomX Therapeutics NASDAQ:CTMX$0.42 -0.04 (-8.47%) As of 11:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.CytomX Therapeutics, Inc, an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. More about CytomX TherapeuticsMarket Capitalization$33.00 millionP/E Ratio2.42Consensus RatingModerate BuyConsensus Price Target$5.02 (+1,104.4% Upside)Volume1.16 million sharesAverage Volume2.65 million shares11. ReShape Lifesciences NASDAQ:RSLS$0.44 -0.02 (-3.26%) As of 11:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. More about ReShape LifesciencesMarket Capitalization$1.47 millionP/E Ratio-0.03Consensus RatingHoldVolume17.18 million sharesAverage Volume2.29 million sharesToday's Range$0.43▼$0.62Remove Ads12. Canoo NASDAQ:GOEV$0.34 -0.07 (-15.95%) Closing price 01/28/2025Extended Trading$0.34 0.00 (0.00%) As of 01/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Canoo Inc, a mobility technology company, designs, develops, markets, and manufactures electric vehicles for consumer, commercial fleet, government, and military customers in the United States. More about CanooMarket Capitalization$1.67 millionP/E Ratio0.00Consensus RatingHoldConsensus Price Target$42.63 (+12,291.0% Upside)Volume6.24 million sharesAverage Volume2.71 million shares13. Nektar Therapeutics NASDAQ:NKTR$0.49 -0.06 (-10.67%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. More about Nektar TherapeuticsMarket Capitalization$93.24 millionP/E Ratio-0.60Consensus RatingBuyConsensus Price Target$4.92 (+897.3% Upside)Volume1.67 million sharesAverage Volume1.85 million shares14. Aethlon Medical NASDAQ:AEMD$0.36 +0.00 (+1.31%) As of 11:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. More about Aethlon MedicalMarket Capitalization$5.13 millionP/E Ratio-0.22Consensus RatingBuyConsensus Price Target$7.00 (+1,871.8% Upside)Volume48,484 sharesAverage Volume2.48 million shares15. Cognition Therapeutics NASDAQ:CGTX$0.33 -0.02 (-5.70%) As of 11:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Cognition Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. More about Cognition TherapeuticsMarket Capitalization$20.82 millionP/E Ratio-0.35Consensus RatingBuyConsensus Price Target$7.13 (+2,033.2% Upside)Volume556,991 sharesAverage Volume2.51 million shares16. TransCode Therapeutics NASDAQ:RNAZ$0.45 -0.01 (-2.66%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.TransCode Therapeutics, Inc, a ribonucleic acid (RNA) oncology company, focuses on the development and commercialization of drugs and diagnostics for treating and identifying various cancers. More about TransCode TherapeuticsMarket Capitalization$5.90 millionConsensus RatingBuyConsensus Price Target$20.00 (+4,384.3% Upside)Volume973,694 sharesAverage Volume1.83 million sharesToday's Range$0.41▼$0.48Remove Ads17. Cardio Diagnostics NASDAQ:CDIO$0.31 +0.00 (+1.47%) As of 11:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. More about Cardio DiagnosticsMarket Capitalization$16.22 millionConsensus RatingBuyConsensus Price Target$2.00 (+545.2% Upside)Volume483,048 sharesAverage Volume2.54 million sharesToday's Range$0.28▼$0.3418. Mersana Therapeutics NASDAQ:MRSN$0.32 +0.01 (+4.66%) As of 11:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Mersana Therapeutics, Inc, a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. More about Mersana TherapeuticsMarket Capitalization$39.38 millionP/E Ratio-0.52Consensus RatingBuyConsensus Price Target$4.00 (+1,161.8% Upside)Volume1.69 million sharesAverage Volume2.44 million shares19. Vaxart NASDAQ:VXRT$0.32 -0.01 (-4.01%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Vaxart, Inc, a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. More about VaxartMarket Capitalization$73.63 millionP/E Ratio-0.79Consensus RatingBuyConsensus Price Target$3.00 (+828.8% Upside)Volume2.02 million sharesAverage Volume2.39 million shares20. ImmunoPrecise Antibodies NASDAQ:IPA$0.37 +0.01 (+1.69%) As of 11:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. More about ImmunoPrecise AntibodiesMarket Capitalization$11.37 millionP/E Ratio-0.47Consensus RatingBuyConsensus Price Target$4.00 (+992.9% Upside)Volume294,460 sharesAverage Volume2.07 million shares21. LeddarTech NASDAQ:LDTC$0.36 -0.05 (-13.00%) As of 11:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.LeddarTech Holdings Inc provides AI-based fusion and perception software solutions for advanced driver assistance solutions and autonomous driving applications in Canada. More about LeddarTechMarket Capitalization$10.47 millionP/E Ratio-0.11Consensus RatingModerate BuyConsensus Price Target$3.00 (+724.2% Upside)Volume217,374 sharesAverage Volume2.08 million shares22. New Horizon Aircraft NASDAQ:HOVR$0.42 -0.03 (-5.56%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.New Horizon Aircraft Ltd., an aerospace original equipment manufacturer company, focuses on designing and developing hybrid electric vertical takeoff and landing (eVTOL) aircraft for the regional air mobility market in the Uinted States. More about New Horizon AircraftMarket Capitalization$13.49 millionConsensus RatingStrong BuyConsensus Price Target$2.00 (+370.6% Upside)Volume129,039 sharesAverage Volume1.69 million sharesToday's Range$0.41▼$0.4523. Asensus Surgical NYSEAMERICAN:ASXC$0.35 0.00 (0.00%) As of 08/22/2024Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. More about Asensus SurgicalMarket Capitalization$94.74 millionP/E Ratio-1.12Consensus RatingHoldConsensus Price Target$0.35 (+0.6% Upside)Average Volume2.03 million sharesToday's Range$0.35▼$0.3524. Unicycive Therapeutics NASDAQ:UNCY$0.48 -0.04 (-7.93%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Unicycive Therapeutics, Inc, a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. More about Unicycive TherapeuticsMarket Capitalization$56.74 millionP/E Ratio-0.49Consensus RatingBuyConsensus Price Target$5.25 (+1,005.3% Upside)Volume1.52 million sharesAverage Volume1.43 million shares25. Brand Engagement Network NASDAQ:BNAI$0.31 0.00 (-0.64%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Brand Engagement Network, Inc provides conversational AI assistants. The company offers security-focused, multimodal communication, and human-like assistants. More about Brand Engagement NetworkMarket Capitalization$12.12 millionConsensus RatingBuyConsensus Price Target$6.00 (+1,841.7% Upside)Volume336,738 sharesAverage Volume2.20 million sharesToday's Range$0.26▼$0.32 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Taiwan Semiconductor Spared From New Tariffs: Bullish Path Ahead? MarketBeat Week in Review – 03/31 - 04/04 Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential? AI Takes Over Search: Is Google's Dominance At Risk? Big Blue's Big Shift: IBM's Turnaround Bet on Cloud and AI Meta Eyes India: Breaking Down Its Quest for Reliance Partnership Goodyear Gains Traction: Shares Climb as Key Catalysts Align Conagra Stock Could Thrive as Tariffs Hit Other Sectors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
